Could a simple pump flow measure predict organ health in heart device patients?

NCT ID NCT07633535

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at people with end-stage heart failure who have a mechanical heart pump (LVAD). It checks whether the pump's flow rate, adjusted for body size, is linked to liver and kidney function and the chance of being readmitted to the hospital. The goal is to see if this measure could help doctors monitor patients better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If a link is found, doctors might use the LVAD index to better predict organ function and readmission risk in heart failure patients with these devices.

What could go wrong

This is a small, observational study with only 34 participants, so results may not apply broadly. It looks for associations, not cause and effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MECHANICAL CIRCULATORY SUPPORT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akdeniz University Faculty of Medicine

    Antalya, 07070, Turkey (Türkiye)